MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517047519 A) filed by Oncoresponse, Inc., Seattle, on May 16, for 'lilrb2 antibody products and methods.'
Inventor(s) include Zuck, Meghan; Probst, Peter; Graddis, Thomas J.; Bouchlaka Bay, Myriam N.; and Puri, Kamal D.
The application for the patent was published on June 6, under issue no. 23/2025.
According to the abstract released by the Intellectual Property India: "The disclosure relates to LILRB2 antibody products and methods of use thereof. The antibody products specifically bind to LILRB2 on cells such as myeloid cells or cancer cells. The antibody products can be used in methods of treatment of disease, such as methods cancer immunotherap...